CLX
CLX
$97.26+0.87%
Setup
Watch
Buy Zone
$97.45-$102.32
Sector
—
Industry
—
37
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
CLX chart
Loading chart…
Overall Quality37
RS Rating
14
relative strength
Fundamentals
45
Weak fund-Q
Volume Demand
82
-38% vs avg
Technical Setup
63
5/8 checks
Industry/Theme
91
Computer Software-Enterprise
Trade Plan
Avoid
Entry
$97.45
Entry Zone
$97.45-$102.32
Stop / Risk
$89.65
RS Rating
14
Volume confirmed
Yes
Targets
$116.94 / $121.81
Breakout · IBD Setup
3 ✓ 5 ✗
Entry $97.45–$102.32Stop $89.65Target $116.94 / $121.81
Market regimeRange
Quality37
RS Rating14
Above 50-MA+3.61%
Above 200-MA-8.94%
VolumeConfirmed
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
37
MarketRange
SetupWatch
ConfidenceExperimental · not backtested
Fund-Q45 · Weak
StatusAvoid
Stock Data
52-Week Range85 – 132
Price % Chg YTD-3.54%
Price % Chg 4wk8.51%
50-Day Avg Vol2.9 Mil
P/E Ratio—
Market Cap$173B
Sector—
Industry—
Company Fundamentals
EPS % Chg (Qtr)—
Sales % Chg (Qtr)—
EPS Growth 5y—
Sales Growth 5y—
Annual ROE—
Gross Margin—
Operating Margin—
Net Margin—
Debt / Equity—
Setup levels
Current price
$97.26
Pivot
$97.45
Distance to buy
-26.3%
52-week range
84.7-132.02
Trigger evidence
No active trigger evidence available.
Financial health checks
0/0
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE—
Net margin—
Gross margin—
EPS growth q/q—
Sales growth q/q—
Debt / equity—
lower is better
Business quality
45
GradeWeak
EPS rating50
P/E—
Market cap$173B
Industry—
Technical checks
Über 50-MA
Pass
Über 200-MA
Fail
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Pass
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-06-29
Trigger date
—
Days on list
5
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.